Farther Finance Advisors’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$11K	Sell	492 -466	-49%	-$11.1K	﹤0.01%	4043
2025 Q4	$25.6K	Buy	958 +386	+67%	+$9.22K	﹤0.01%	3274
2025 Q3	$12.2K	Sell	572 -271	-32%	-$6.41K	﹤0.01%	3348
2025 Q2	$18.2K	Buy	843 +509	+152%	+$9.46K	﹤0.01%	2743
2025 Q1	$5.45K	Hold	334	–	–	﹤0.01%	3017
2024 Q4	$6.13K	Buy	334 +45	+16%	+$726	﹤0.01%	2576
2024 Q3	$4.45K	Hold	289	–	–	﹤0.01%	2694
2024 Q2	$4.64K	Sell	289 -1,455	-83%	-$23.5K	﹤0.01%	2428
2024 Q1	$31.8K	Hold	1,744	–	–	﹤0.01%	1343
2023 Q4	$54.6K	Buy	1,744 +1,490	+587%	+$35.6K	﹤0.01%	1006
2023 Q3	$5.29K	Hold	254	–	–	﹤0.01%	1502
2023 Q2	$6.08K	Hold	254	–	–	﹤0.01%	1358
2023 Q1	$4.78K	Hold	254	–	–	﹤0.01%	1356
2022 Q4	$4.04K	Buy	+254	New	+$3.97K	﹤0.01%	1238